Mengbi Yang current role focuses on preclinical pharmacokinetic, pharmacodynamic, and toxicological assessments to support early-stage drug discovery and development. She works closely with project teams to inform drug candidate screening and translational strategies, with particular focuses in new therapeutic modalities, such as peptides, oligonucleotide-based therapeutics, and therapeutic antibodies, in early development.